D-Cycloserine acts via increasing the GluN1 protein expressions in the frontal cortex and decreases the avoidance and risk assessment behaviors in a rat traumatic stress model.

Abstract

D-cycloserine (DCS), an FDA approved anti-tuberculosis drug has extensively been studied for its cognitive enhancer effects in psychiatric disorders. DCS may enhance the effects of fear extinction trainings in animals during exposure therapy and hence we investigated the effects of DCS on distinct behavioral parameters in a predator odor stress model and… (More)
DOI: 10.1016/j.bbr.2015.07.050

Topics

Cite this paper

@article{Sardoan2015DCycloserineAV, title={D-Cycloserine acts via increasing the GluN1 protein expressions in the frontal cortex and decreases the avoidance and risk assessment behaviors in a rat traumatic stress model.}, author={G{\"{o}kçe Elif Sarıdoğan and Aslı Aykaç and H{\"{u}lya Cabadak and Cem Cerit and Mecit Çalışkan and Mehmet Zafer G{\"{o}ren}, journal={Behavioural brain research}, year={2015}, volume={293}, pages={227-33} }